CRISPR is a personal net-zero token serving three distinct purposes: incentivizing, rewarding, and investing in the future of our health and planet.
Based in Silicon Valley, Berkeley Pharma Tech is a biotechnology incubator for today’s young scientists. We are making strides toward medical revolutions through a variety of avenues, including biomedical research, cryptocurrency engineering, and software development. Our goal for the CRISPR project is to create a cleaner, more vibrant environment for the next generation, with net zero—a state of balance between the amount of greenhouse gas emissions and their removal from the atmosphere—being a focal point. For more information about the CRISPR project and Berkeley Pharma Tech, visit our website or any of our social media channels below.
